AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals Post author:GIBoardReview.com Post published:February 14, 2025 Post category:Society Guidelines You Might Also Like AGA Clinical Practice Update on Endoscopic Enteral Access: Commentary December 20, 2024 AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review June 1, 2019 AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review June 1, 2019
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023